CDIOW — Cardio Diagnostics Holdings, Inc.

Open full analysis

Chart, dilution, float and news for CDIOW in the TickerWise workspace.

Cardio Diagnostics Holdings, Inc. develops and commercializes epigenetics-based clinical tests for cardiovascular disease. It offers Epi+Gen CHD, a three-year symptomatic coronary heart disease risk assessment test. Cardio Diagnostics Holdings, Inc. was founded in 2017 and is based in Chicago, Illinois.

Company profile

• Sector: Healthcare
• Industry: Biotechnology
• Country: US
• Exchange: NASDAQ
• Employees: 13
• Website: https://cardiodiagnosticsinc.com

Latest SEC filings for CDIOW

• 2026-07-23ARS
• 2026-02-198-K

Open full analysis

Educational tool only — not investment advice.